To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Fluacizine possesses strong central and peripheral anticholinergic activity.
Additional recommended knowledge
Fluacizine is indicated in bipolar depression, the emotional problems accompanying schizophrenia, anxiety accompanying depression, and for the depressive and extrapyramidal symptoms resulting from neuroleptic therapy. It is not effective for atypical depression or late-onset depression (once known as involutional melancholia).
Side effects of fluacizine include feeling of weakness, nausea, and dry mouth.
Fluacizine is contraindicated in patients with liver or kidney impairment, enlarged prostate, peptic ulcer or who have taken MAOIs less than 14 days before starting therapy.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fluacizine". A list of authors is available in Wikipedia.|